Clinical Trial Registration Number: 2020 KY-131 Supported by: Strategic Priority Research Program of Chinese Academy of Sciences (XDB38000000)
doi: 10.1111/nure.12012 Summary Keywords amino acid metabolism, diabetic kidney disease, functional foods, gut microbiota, gut-liver-kidney axis, medicine food homology, natural bioactive compounds, uremic toxins Citation Sun L, Sun G, Nan Y, Wang H, Sun Y, Shi Y, Yang Y and Wang Q (2026) Gut microbiota-liver-kidney axis in diabetic kidney disease: mechanistic insights into amino acid metabolism and nutritional intervention strategies targeting natural bioactive compounds
However, as with any medication, HGH has some potential side effects
Lihn AS, Pedersen SB, Richelsen B